Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging

Pulmonary hypertension is a heterogeneous disease, and a significant portion of patients at risk for it have CT imaging available. Advanced automated processing techniques could be leveraged for early detection, screening, and development of quantitative phenotypes. Pruning and vascular tortuosity h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chest 2021-12, Vol.160 (6), p.2220-2231
Hauptverfasser: Rahaghi, Farbod N., Nardelli, Pietro, Harder, Eileen, Singh, Inderjit, Sánchez-Ferrero, Gonzalo Vegas, Ross, James C., San José Estépar, Rubén, Ash, Samuel Y., Hunsaker, Andetta R., Maron, Bradley A., Leopold, Jane A., Waxman, Aaron B., San José Estépar, Raúl, Washko, George R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2231
container_issue 6
container_start_page 2220
container_title Chest
container_volume 160
creator Rahaghi, Farbod N.
Nardelli, Pietro
Harder, Eileen
Singh, Inderjit
Sánchez-Ferrero, Gonzalo Vegas
Ross, James C.
San José Estépar, Rubén
Ash, Samuel Y.
Hunsaker, Andetta R.
Maron, Bradley A.
Leopold, Jane A.
Waxman, Aaron B.
San José Estépar, Raúl
Washko, George R.
description Pulmonary hypertension is a heterogeneous disease, and a significant portion of patients at risk for it have CT imaging available. Advanced automated processing techniques could be leveraged for early detection, screening, and development of quantitative phenotypes. Pruning and vascular tortuosity have been previously described in pulmonary arterial hypertension (PAH), but the extent of these phenomena in arterial vs venous pulmonary vasculature and in exercise pulmonary hypertension (ePH) have not been described. What are the arterial and venous manifestations of pruning and vascular tortuosity using CT imaging in PAH, and do they also occur in ePH? A cohort of patients with PAH and ePH and control subjects with available CT angiograms were retrospectively identified to examine the differential arterial and venous presence of pruning and tortuosity in patients with precapillary pulmonary hypertension not confounded by lung or thromboembolic disease. The pulmonary vasculature was reconstructed, and an artificial intelligence method was used to separate arteries and veins and to compute arterial and venous vascular volumes and tortuosity. A total of 42 patients with PAH, 12 patients with ePH, and 37 control subjects were identified. There was relatively lower (median [interquartile range]) arterial small vessel volume in subjects with PAH (PAH 14.7 [11.7-16.5; P < .0001]) vs control subjects (16.9 [15.6-19.2]) and venous small vessel volume in subjects with PAH and ePH (PAH 8.0 [6.5-9.6; P < .0001]; ePH, 7.8 [7.5-11.4; P = .004]) vs control subjects (11.5 [10.6-12.2]). Higher large arterial volume, however, was only observed in the pulmonary arteries (PAH 17.1 [13.6-23.4; P < .0001] vs control subjects 11.4 [8.1-15.4]). Similarly, tortuosity was higher in the pulmonary arteries in the PAH group (PAH 3.5 [3.3-3.6; P = .0002] vs control 3.2 [3.2-3.3]). Lower small distal pulmonary vascular volume, higher proximal arterial volume, and higher arterial tortuosity were observed in PAH. These can be quantified by using automated techniques from clinically acquired CT scans of patients with ePH and resting PAH. [Display omitted]
doi_str_mv 10.1016/j.chest.2021.06.069
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8692106</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S001236922101326X</els_id><sourcerecordid>2552990484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-a1930800759b018c222652f81acd7c2e5436f74c6f21176ef043217381c10a3</originalsourceid><addsrcrecordid>eNp9UU1r3DAQFaWl2aT9BYWiYy_ejCRbtg4thCVfkNCEpr0KRR7vamtLG8kO5N9Hm03S9lIY0Ax682bmPUI-MZgzYPJwPbcrTOOcA2dzkDnUGzJjSrBCVKV4S2YAjBdCKr5H9lNaQ66Zku_Jnih5DUrKGRmuJ-NH1zlrRhc8DR09iiNGZ3pqfEt_oQ9TopchblahD0tn6aWJvzEm6jy9mvoheBMf_jSdPWww5z5t2X4m55d0cUPPB7PM6QfyrjN9wo_P7wH5cXJ8szgrLr6fni-OLgpbVmosTD4CGoC6UrfAGss5lxXvGmZsW1uO-TrZ1aWVHWeslthBKTirRcMsAyMOyLcd62a6HbC16Mdoer2Jbsir6mCc_vfHu5VehnvdZKkYyEzw5Zkghrspa6wHlyz2vfGY1dC8qrhSUDZlhood1MaQUsTudQwDvbVJr_WTTXprkwaZQ-Wuz39v-Nrz4ksGfN0BMKt07zDqZB16i62LaEfdBvffAY_MNqYn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2552990484</pqid></control><display><type>article</type><title>Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Rahaghi, Farbod N. ; Nardelli, Pietro ; Harder, Eileen ; Singh, Inderjit ; Sánchez-Ferrero, Gonzalo Vegas ; Ross, James C. ; San José Estépar, Rubén ; Ash, Samuel Y. ; Hunsaker, Andetta R. ; Maron, Bradley A. ; Leopold, Jane A. ; Waxman, Aaron B. ; San José Estépar, Raúl ; Washko, George R.</creator><creatorcontrib>Rahaghi, Farbod N. ; Nardelli, Pietro ; Harder, Eileen ; Singh, Inderjit ; Sánchez-Ferrero, Gonzalo Vegas ; Ross, James C. ; San José Estépar, Rubén ; Ash, Samuel Y. ; Hunsaker, Andetta R. ; Maron, Bradley A. ; Leopold, Jane A. ; Waxman, Aaron B. ; San José Estépar, Raúl ; Washko, George R.</creatorcontrib><description>Pulmonary hypertension is a heterogeneous disease, and a significant portion of patients at risk for it have CT imaging available. Advanced automated processing techniques could be leveraged for early detection, screening, and development of quantitative phenotypes. Pruning and vascular tortuosity have been previously described in pulmonary arterial hypertension (PAH), but the extent of these phenomena in arterial vs venous pulmonary vasculature and in exercise pulmonary hypertension (ePH) have not been described. What are the arterial and venous manifestations of pruning and vascular tortuosity using CT imaging in PAH, and do they also occur in ePH? A cohort of patients with PAH and ePH and control subjects with available CT angiograms were retrospectively identified to examine the differential arterial and venous presence of pruning and tortuosity in patients with precapillary pulmonary hypertension not confounded by lung or thromboembolic disease. The pulmonary vasculature was reconstructed, and an artificial intelligence method was used to separate arteries and veins and to compute arterial and venous vascular volumes and tortuosity. A total of 42 patients with PAH, 12 patients with ePH, and 37 control subjects were identified. There was relatively lower (median [interquartile range]) arterial small vessel volume in subjects with PAH (PAH 14.7 [11.7-16.5; P &lt; .0001]) vs control subjects (16.9 [15.6-19.2]) and venous small vessel volume in subjects with PAH and ePH (PAH 8.0 [6.5-9.6; P &lt; .0001]; ePH, 7.8 [7.5-11.4; P = .004]) vs control subjects (11.5 [10.6-12.2]). Higher large arterial volume, however, was only observed in the pulmonary arteries (PAH 17.1 [13.6-23.4; P &lt; .0001] vs control subjects 11.4 [8.1-15.4]). Similarly, tortuosity was higher in the pulmonary arteries in the PAH group (PAH 3.5 [3.3-3.6; P = .0002] vs control 3.2 [3.2-3.3]). Lower small distal pulmonary vascular volume, higher proximal arterial volume, and higher arterial tortuosity were observed in PAH. These can be quantified by using automated techniques from clinically acquired CT scans of patients with ePH and resting PAH. [Display omitted]</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1016/j.chest.2021.06.069</identifier><identifier>PMID: 34270966</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; arterial ; CT imaging ; exercise pulmonary hypertension ; Female ; Humans ; Male ; Middle Aged ; pulmonary arterial hypertension ; Pulmonary Arterial Hypertension - diagnostic imaging ; Pulmonary Arterial Hypertension - physiopathology ; Pulmonary Artery - diagnostic imaging ; Pulmonary Artery - physiopathology ; Pulmonary Vascular: Original Research ; Pulmonary Veins - diagnostic imaging ; Pulmonary Veins - physiopathology ; Respiratory Function Tests ; Retrospective Studies ; Tomography, X-Ray Computed ; tortuosity ; venous</subject><ispartof>Chest, 2021-12, Vol.160 (6), p.2220-2231</ispartof><rights>2021 The Authors</rights><rights>Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.</rights><rights>2021 The Authors 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-a1930800759b018c222652f81acd7c2e5436f74c6f21176ef043217381c10a3</citedby><cites>FETCH-LOGICAL-c459t-a1930800759b018c222652f81acd7c2e5436f74c6f21176ef043217381c10a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34270966$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rahaghi, Farbod N.</creatorcontrib><creatorcontrib>Nardelli, Pietro</creatorcontrib><creatorcontrib>Harder, Eileen</creatorcontrib><creatorcontrib>Singh, Inderjit</creatorcontrib><creatorcontrib>Sánchez-Ferrero, Gonzalo Vegas</creatorcontrib><creatorcontrib>Ross, James C.</creatorcontrib><creatorcontrib>San José Estépar, Rubén</creatorcontrib><creatorcontrib>Ash, Samuel Y.</creatorcontrib><creatorcontrib>Hunsaker, Andetta R.</creatorcontrib><creatorcontrib>Maron, Bradley A.</creatorcontrib><creatorcontrib>Leopold, Jane A.</creatorcontrib><creatorcontrib>Waxman, Aaron B.</creatorcontrib><creatorcontrib>San José Estépar, Raúl</creatorcontrib><creatorcontrib>Washko, George R.</creatorcontrib><title>Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging</title><title>Chest</title><addtitle>Chest</addtitle><description>Pulmonary hypertension is a heterogeneous disease, and a significant portion of patients at risk for it have CT imaging available. Advanced automated processing techniques could be leveraged for early detection, screening, and development of quantitative phenotypes. Pruning and vascular tortuosity have been previously described in pulmonary arterial hypertension (PAH), but the extent of these phenomena in arterial vs venous pulmonary vasculature and in exercise pulmonary hypertension (ePH) have not been described. What are the arterial and venous manifestations of pruning and vascular tortuosity using CT imaging in PAH, and do they also occur in ePH? A cohort of patients with PAH and ePH and control subjects with available CT angiograms were retrospectively identified to examine the differential arterial and venous presence of pruning and tortuosity in patients with precapillary pulmonary hypertension not confounded by lung or thromboembolic disease. The pulmonary vasculature was reconstructed, and an artificial intelligence method was used to separate arteries and veins and to compute arterial and venous vascular volumes and tortuosity. A total of 42 patients with PAH, 12 patients with ePH, and 37 control subjects were identified. There was relatively lower (median [interquartile range]) arterial small vessel volume in subjects with PAH (PAH 14.7 [11.7-16.5; P &lt; .0001]) vs control subjects (16.9 [15.6-19.2]) and venous small vessel volume in subjects with PAH and ePH (PAH 8.0 [6.5-9.6; P &lt; .0001]; ePH, 7.8 [7.5-11.4; P = .004]) vs control subjects (11.5 [10.6-12.2]). Higher large arterial volume, however, was only observed in the pulmonary arteries (PAH 17.1 [13.6-23.4; P &lt; .0001] vs control subjects 11.4 [8.1-15.4]). Similarly, tortuosity was higher in the pulmonary arteries in the PAH group (PAH 3.5 [3.3-3.6; P = .0002] vs control 3.2 [3.2-3.3]). Lower small distal pulmonary vascular volume, higher proximal arterial volume, and higher arterial tortuosity were observed in PAH. These can be quantified by using automated techniques from clinically acquired CT scans of patients with ePH and resting PAH. [Display omitted]</description><subject>Adult</subject><subject>Aged</subject><subject>arterial</subject><subject>CT imaging</subject><subject>exercise pulmonary hypertension</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>pulmonary arterial hypertension</subject><subject>Pulmonary Arterial Hypertension - diagnostic imaging</subject><subject>Pulmonary Arterial Hypertension - physiopathology</subject><subject>Pulmonary Artery - diagnostic imaging</subject><subject>Pulmonary Artery - physiopathology</subject><subject>Pulmonary Vascular: Original Research</subject><subject>Pulmonary Veins - diagnostic imaging</subject><subject>Pulmonary Veins - physiopathology</subject><subject>Respiratory Function Tests</subject><subject>Retrospective Studies</subject><subject>Tomography, X-Ray Computed</subject><subject>tortuosity</subject><subject>venous</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU1r3DAQFaWl2aT9BYWiYy_ejCRbtg4thCVfkNCEpr0KRR7vamtLG8kO5N9Hm03S9lIY0Ax682bmPUI-MZgzYPJwPbcrTOOcA2dzkDnUGzJjSrBCVKV4S2YAjBdCKr5H9lNaQ66Zku_Jnih5DUrKGRmuJ-NH1zlrRhc8DR09iiNGZ3pqfEt_oQ9TopchblahD0tn6aWJvzEm6jy9mvoheBMf_jSdPWww5z5t2X4m55d0cUPPB7PM6QfyrjN9wo_P7wH5cXJ8szgrLr6fni-OLgpbVmosTD4CGoC6UrfAGss5lxXvGmZsW1uO-TrZ1aWVHWeslthBKTirRcMsAyMOyLcd62a6HbC16Mdoer2Jbsir6mCc_vfHu5VehnvdZKkYyEzw5Zkghrspa6wHlyz2vfGY1dC8qrhSUDZlhood1MaQUsTudQwDvbVJr_WTTXprkwaZQ-Wuz39v-Nrz4ksGfN0BMKt07zDqZB16i62LaEfdBvffAY_MNqYn</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Rahaghi, Farbod N.</creator><creator>Nardelli, Pietro</creator><creator>Harder, Eileen</creator><creator>Singh, Inderjit</creator><creator>Sánchez-Ferrero, Gonzalo Vegas</creator><creator>Ross, James C.</creator><creator>San José Estépar, Rubén</creator><creator>Ash, Samuel Y.</creator><creator>Hunsaker, Andetta R.</creator><creator>Maron, Bradley A.</creator><creator>Leopold, Jane A.</creator><creator>Waxman, Aaron B.</creator><creator>San José Estépar, Raúl</creator><creator>Washko, George R.</creator><general>Elsevier Inc</general><general>American College of Chest Physicians</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211201</creationdate><title>Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging</title><author>Rahaghi, Farbod N. ; Nardelli, Pietro ; Harder, Eileen ; Singh, Inderjit ; Sánchez-Ferrero, Gonzalo Vegas ; Ross, James C. ; San José Estépar, Rubén ; Ash, Samuel Y. ; Hunsaker, Andetta R. ; Maron, Bradley A. ; Leopold, Jane A. ; Waxman, Aaron B. ; San José Estépar, Raúl ; Washko, George R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-a1930800759b018c222652f81acd7c2e5436f74c6f21176ef043217381c10a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>arterial</topic><topic>CT imaging</topic><topic>exercise pulmonary hypertension</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>pulmonary arterial hypertension</topic><topic>Pulmonary Arterial Hypertension - diagnostic imaging</topic><topic>Pulmonary Arterial Hypertension - physiopathology</topic><topic>Pulmonary Artery - diagnostic imaging</topic><topic>Pulmonary Artery - physiopathology</topic><topic>Pulmonary Vascular: Original Research</topic><topic>Pulmonary Veins - diagnostic imaging</topic><topic>Pulmonary Veins - physiopathology</topic><topic>Respiratory Function Tests</topic><topic>Retrospective Studies</topic><topic>Tomography, X-Ray Computed</topic><topic>tortuosity</topic><topic>venous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahaghi, Farbod N.</creatorcontrib><creatorcontrib>Nardelli, Pietro</creatorcontrib><creatorcontrib>Harder, Eileen</creatorcontrib><creatorcontrib>Singh, Inderjit</creatorcontrib><creatorcontrib>Sánchez-Ferrero, Gonzalo Vegas</creatorcontrib><creatorcontrib>Ross, James C.</creatorcontrib><creatorcontrib>San José Estépar, Rubén</creatorcontrib><creatorcontrib>Ash, Samuel Y.</creatorcontrib><creatorcontrib>Hunsaker, Andetta R.</creatorcontrib><creatorcontrib>Maron, Bradley A.</creatorcontrib><creatorcontrib>Leopold, Jane A.</creatorcontrib><creatorcontrib>Waxman, Aaron B.</creatorcontrib><creatorcontrib>San José Estépar, Raúl</creatorcontrib><creatorcontrib>Washko, George R.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahaghi, Farbod N.</au><au>Nardelli, Pietro</au><au>Harder, Eileen</au><au>Singh, Inderjit</au><au>Sánchez-Ferrero, Gonzalo Vegas</au><au>Ross, James C.</au><au>San José Estépar, Rubén</au><au>Ash, Samuel Y.</au><au>Hunsaker, Andetta R.</au><au>Maron, Bradley A.</au><au>Leopold, Jane A.</au><au>Waxman, Aaron B.</au><au>San José Estépar, Raúl</au><au>Washko, George R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>160</volume><issue>6</issue><spage>2220</spage><epage>2231</epage><pages>2220-2231</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><abstract>Pulmonary hypertension is a heterogeneous disease, and a significant portion of patients at risk for it have CT imaging available. Advanced automated processing techniques could be leveraged for early detection, screening, and development of quantitative phenotypes. Pruning and vascular tortuosity have been previously described in pulmonary arterial hypertension (PAH), but the extent of these phenomena in arterial vs venous pulmonary vasculature and in exercise pulmonary hypertension (ePH) have not been described. What are the arterial and venous manifestations of pruning and vascular tortuosity using CT imaging in PAH, and do they also occur in ePH? A cohort of patients with PAH and ePH and control subjects with available CT angiograms were retrospectively identified to examine the differential arterial and venous presence of pruning and tortuosity in patients with precapillary pulmonary hypertension not confounded by lung or thromboembolic disease. The pulmonary vasculature was reconstructed, and an artificial intelligence method was used to separate arteries and veins and to compute arterial and venous vascular volumes and tortuosity. A total of 42 patients with PAH, 12 patients with ePH, and 37 control subjects were identified. There was relatively lower (median [interquartile range]) arterial small vessel volume in subjects with PAH (PAH 14.7 [11.7-16.5; P &lt; .0001]) vs control subjects (16.9 [15.6-19.2]) and venous small vessel volume in subjects with PAH and ePH (PAH 8.0 [6.5-9.6; P &lt; .0001]; ePH, 7.8 [7.5-11.4; P = .004]) vs control subjects (11.5 [10.6-12.2]). Higher large arterial volume, however, was only observed in the pulmonary arteries (PAH 17.1 [13.6-23.4; P &lt; .0001] vs control subjects 11.4 [8.1-15.4]). Similarly, tortuosity was higher in the pulmonary arteries in the PAH group (PAH 3.5 [3.3-3.6; P = .0002] vs control 3.2 [3.2-3.3]). Lower small distal pulmonary vascular volume, higher proximal arterial volume, and higher arterial tortuosity were observed in PAH. These can be quantified by using automated techniques from clinically acquired CT scans of patients with ePH and resting PAH. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34270966</pmid><doi>10.1016/j.chest.2021.06.069</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-3692
ispartof Chest, 2021-12, Vol.160 (6), p.2220-2231
issn 0012-3692
1931-3543
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8692106
source MEDLINE; Alma/SFX Local Collection
subjects Adult
Aged
arterial
CT imaging
exercise pulmonary hypertension
Female
Humans
Male
Middle Aged
pulmonary arterial hypertension
Pulmonary Arterial Hypertension - diagnostic imaging
Pulmonary Arterial Hypertension - physiopathology
Pulmonary Artery - diagnostic imaging
Pulmonary Artery - physiopathology
Pulmonary Vascular: Original Research
Pulmonary Veins - diagnostic imaging
Pulmonary Veins - physiopathology
Respiratory Function Tests
Retrospective Studies
Tomography, X-Ray Computed
tortuosity
venous
title Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T11%3A39%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantification%20of%20Arterial%20and%20Venous%20Morphologic%20Markers%20in%20Pulmonary%20Arterial%20Hypertension%20Using%20CT%20Imaging&rft.jtitle=Chest&rft.au=Rahaghi,%20Farbod%20N.&rft.date=2021-12-01&rft.volume=160&rft.issue=6&rft.spage=2220&rft.epage=2231&rft.pages=2220-2231&rft.issn=0012-3692&rft.eissn=1931-3543&rft_id=info:doi/10.1016/j.chest.2021.06.069&rft_dat=%3Cproquest_pubme%3E2552990484%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2552990484&rft_id=info:pmid/34270966&rft_els_id=S001236922101326X&rfr_iscdi=true